» Articles » PMID: 39406917

Improved Ex Vivo Fluorescence Imaging of Human Head and Neck Cancer Using the Peptide Tracer TPP-IRDye800 Targeting Membrane-bound Hsp70 on Tumor Cells

Abstract

Background: The primary goal of surgery in HNSCC is the complete resection of tumor cells with maximum preservation of normal tissue. The membrane Hsp70-targeting fluorescence labelled peptide TPP-IRDye800 represents a promising tool for real-time intraoperative tumor visualization, enabling the detection of true tumor margins, critical isles of high-grade dysplasia and LN metastases.

Methods: Membrane Hsp70 (mHsp70) expression on HNSCC cell lines and primary HNSCC was determined by flow cytometry and fluorescence microscopy using FITC-conjugated mAb cmHsp70.1 and TPP. TPP-IRDye800 was sprayed on freshly resected tumor material of immunohistochemically confirmed HNSCC and LN metastases for tumor imaging. TBRs were compared using TPP-IRDye800 and Cetuximab-IRDye680, recognizing EGFR.

Results: mHsp70 expressing HNSCC cells specifically bind and internalize TPP in vitro. The TBR (2.56 ± 0.39) and AUC [0.98 CI, 0.95-1.00 vs. 0.91 CI, 0.85-0.97] of TPP-IRDye800 on primary HNSCC was significantly higher than Cetuximab-IRDye680 (1.61 ± 0.39) (p = 0.0068) and TPP-IRDye800 provided a superior tumor delineation. Fluorescence imaging showed higher AUC values than a visual inspection by surgeons [0.97 CI, 0.94-1.00 vs. 0.92 CI, 0.88-0.97] (p = 0.048). LN metastases could be visualized using TPP-IRDye800. Real-time tissue delineation was confirmed using the clinically applied KARL-STORZ imaging system.

Conclusion: TPP-IRDye800 is a promising fluorescence imaging probe for HNSCC.

References
1.
Gao R, Teraphongphom N, de Boer E, van den Berg N, Divi V, Kaplan M . Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers. Theranostics. 2018; 8(9):2488-2495. PMC: 5928904. DOI: 10.7150/thno.24487. View

2.
Liao J, Lowthert L, Ghori N, Omary M . The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem. 1995; 270(2):915-22. DOI: 10.1074/jbc.270.2.915. View

3.
Stangl S, Varga J, Freysoldt B, Trajkovic-Arsic M, Siveke J, Greten F . Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe. Cancer Res. 2014; 74(23):6903-12. DOI: 10.1158/0008-5472.CAN-14-0413. View

4.
Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, De Maio A . Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS One. 2008; 3(4):e1925. PMC: 2271151. DOI: 10.1371/journal.pone.0001925. View

5.
Xanthopoulos A, Samt A, Guder C, Taylor N, Roberts E, Herf H . Hsp70-A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers. Biomedicines. 2023; 11(8). PMC: 10452093. DOI: 10.3390/biomedicines11082276. View